bretylium has been researched along with oxidopamine in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
McGrath, JC | 1 |
Cunnane, TC; Jackson, VM | 1 |
2 other study(ies) available for bretylium and oxidopamine
Article | Year |
---|---|
Bretylium or 6-OHDA-resistant, action potential-evoked Ca2+ transients in varicosities of the mouse vas deferens: commentary on Jackson and Cunnane.
Topics: Action Potentials; Adrenergic Agents; Animals; Bretylium Compounds; Calcium; Drug Resistance; Male; Mice; Oxidopamine; Vas Deferens | 2002 |
Bretylium or 6-OHDA-resistant, action potential-evoked Ca2+ transients in varicosities of the mouse vas deferens.
Topics: Action Potentials; Adrenergic Agents; Adrenergic Fibers; Animals; Anti-Arrhythmia Agents; Bretylium Compounds; Calcium; Drug Resistance; Male; Mice; Mice, Inbred BALB C; Oxidopamine; Vas Deferens | 2002 |